⌘K

Login Start Free

Home/Filings/4/0001213900-22-084089

4//SEC Filing

MILLS ROBERT S 4

Accession 0001213900-22-084089

CIK 0001733413other

View on SEC.gov Company Profile

Filed

Dec 29, 7:00 PM ET

Accepted

Dec 30, 4:53 PM ET

Size

5.3 KB

Accession

0001213900-22-084089

Insider Transaction Report

Form 4

Period: 2022-12-29

TFF Pharmaceuticals, Inc.TFFP

Director

Transactions

Award
Stock Options (Right to Buy)
2022-12-29+33,475→ 33,475 total
Exercise: $0.85From: 2023-12-29Exp: 2032-12-29→ Common Stock (33,475 underlying)

Footnotes (1)

[F1]The options represent the annual option grant to non-executive members of the Board of Directors.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TFF Pharmaceuticals, Inc.

CIK 0001733413

Entity typeother

Related Parties

1

filerCIK 0001240140

Filing Metadata

Form type: 4
Filed: Dec 29, 7:00 PM ET
Accepted: Dec 30, 4:53 PM ET
Size: 5.3 KB

View on SEC.gov